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1. Introduction 
1.1 Tissue Engineering 
The field of tissue engineering (regenerative medicine) aims to repair and regenerate 
damaged tissues by developing biological substitutes that mimic the natural extracellular 
matrix to help guide the growth of new functional tissue in vitro or in vivo to restore, 
maintain or improve tissue function. Tissue engineering technologies are based on a 
biological triad and involve the successful interaction between three components: (1) the 
scaffold that holds the cells together to create the tissue’s physical form, (2) the cells that 
synthesise the tissue and (3) signalling mechanisms (i.e. mechanical and chemical signals) 
that direct the cells to express the desired tissue phenotype (Langer & Vacanti, 1993). 
Bioreactors can be used to provide the signals in this latter area in order to influence 
biological processes by the application of a mechanical stimulus, and may also be used as an 
alternative to, or in conjunction with growth factors.  
 Fig. 1. The tissue engineering triad; factors that need to be considered when designing a 
suitable structure for tissue engineering applications (Lyons, et al., 2008). 
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1.2 Use of Bioreactors in Tissue Engineering  
A tissue engineering bioreactor can be defined as a device that uses mechanical means to 
influence biological processes (Darling & Athanasiou, 2003). Bioreactors can be used to aid 
in the in vitro development of new tissue by providing biochemical and physical regulatory 
signals to cells and encouraging them to undergo differentiation and/or to produce 
extracellular matrix prior to in vivo implantation. Bioreactors are devices in which biological 
or biochemical processes develop under a closely monitored and tightly controlled 
environment.  
Cells respond to mechanical stimulation and bioreactors can be used to apply mechanical 
stimulation to cells. This can encourage cells to produce extracellular matrix (ECM) in a 
shorter time period and in a more homogeneous manner than would be the case with static 
culture. For example, in comparisons between ECM protein levels of equine articluar 
chondrocytes cultured on polyglycolic acid scaffolds after 5 weeks in culture, constructs 
cultured under hydrostatic pressure showed significant improvements over constructs 
cultured in static medium (Carver & Heath, 1999). A benefit of ECM production is the 
increase in mechanical stiffness that it provides to the construct. A six-fold increase in 
equilibrium aggregate modulus (an intrinsic property of cartilage which is a measure of 
stiffness) was found after 28 days of culture in a compression bioreactor compared to free 
swelling controls (Mauck, et al., 2000). Another important application of bioreactors is in 
cellular differentiation. Mechanical stimulation can be used to encourage stem cells down a 
particular path and hence provide the cell phenotype required. Bioreactors can provide 
biochemical and physical regulatory signals that guide differentiation (Altman, et al., 2002). 
There is great potential for using mesenchymal stem cells and other multipotent cells to 
generate different cell types and bioreactors can play an important role in this process. 
As well as providing mechanical stimulation, bioreactors can also be used to improve 
cellular spatial distribution. A heterogeneous cell distribution is a major obstacle to 
developing any three-dimensional tissue or organ in vitro. Defects requiring tissue 
engineering solutions are typically many millimetres in size (Goldstein, et al., 2001). 
Scaffolds in such a size range are easily fabricated, however, problems arise when culturing 
cells on these scaffolds. As the size of the scaffold increases, diffusion of nutrients to the 
centre of the construct becomes more difficult. Static culture conditions result in scaffolds 
with few cells in the centre of the construct (Cartmell, et al., 2003). It is hypothesised that this 
is due to limited cell penetration during seeding, cell migration to the scaffold periphery 
during culture, or cell death in the centre of the scaffold (Glowacki, et al., 1998, Ishaug-Riley, 
et al., 1998, Goldstein, et al., 2001, Yu, et al., 2004, Gomes, et al., 2005). The only mechanism by 
which nutrients and waste can move when a scaffold is in static culture is by diffusion. It 
has been shown that despite homogeneous cell seeding, after long periods in culture, more 
cells are found on the periphery of constructs (Cartmell, et al., 2003) leading to peripheral 
encapsulation which hinders nutrient and waste exchange from the centre, resulting in core 
degradation of tissue engineered constructs. This is of major concern in the field of tissue 
engineering, and is a major obstacle in the formation of a viable tissue in vitro. For this 
reason, for a number of tissue types, the move towards clinical trials has been slow and 
progress to date in engineering significant quantities of functional tissue in vitro for 
implantation in humans in vivo has been somewhat disappointing.  
Thus, bioreactors can be used in tissue engineering applications to overcome problems 
associated with traditional static culture conditions, improve cellular distribution and 
 
accelerate construct maturation (Freed, et al., 2006) whilst applying biophysical signals to 
constructs to improve tissue formation in vitro prior to in vivo implantation. In general, 
bioreactors are designed to perform at least one of the following five functions, to (1) 
provide a spatially uniform cell distribution, (2) maintain the desired concentration of gases 
and nutrients in culture medium, (3) facilitate mass transport to the tissue, (4) expose the 
construct to physical stimuli and/or (5) provide information about the formation of 3D 
tissue (Vunjak-Novakovic, et al., 1998, Bancroft, et al., 2003)  
 
1.3 Bioreactor Design Requirements  
The design of the bioreactor should be as simple as possible e.g. avoiding the introduction of 
machined recesses which could become breeding grounds for micro-organisms. Simplicity 
in design should also mean that the bioreactor is quick to assemble and disassemble. Apart 
from being more efficient, this ensures that cell-seeded constructs inserted into the 
bioreactor are out of the incubator for the minimum amount of time possible. This 
minimises the risk to the cells and the experiment being undertaken. 
The detailed requirements for bioreactor design are tissue- and/or application- specific, 
however, there are a few general principles which have to be adhered to when developing a 
bioreactor. The material selection is very important as it is vital to ensure that the materials 
used to create the bioreactor do not elicit any adverse reaction from the cultured tissue. Any 
material which is in contact with media must be biocompatible or bioinert. This eliminates 
the use of most metals, although stainless steel can be used if it is treated so that chromium 
ions do not leach out into the medium. Numerous plastics comply with this constraint but 
there are further limitations on material selection that must also be kept in mind. Materials 
must be usable at 37°C in a humid atmosphere. They must be able to be sterilised if they are 
to be re-used. Bioreactor parts can be sterilised by autoclaving or disinfected by submersion 
in alcohol. If they are to be autoclaved, materials that can withstand numerous cycles of high 
temperature and pressure must be used in bioreactor manufacture. Alternatively, some non-
sterilisable disposable bioreactor parts may be used which can be replaced after each use of 
the bioreactor. Other material choices are between transparent or opaque and flexible or 
inflexible materials. Materials with different properties are needed for various components 
in the bioreactor. For example, transparent materials can be of benefit in allowing the 
construct to be monitored in the bioreactor during culture while flexible tubing can help 
with assembly of the bioreactor. 
The specific application of the bioreactor must be kept in mind during the design process to 
ensure that all the design constraints are met. If various parameters such as pH, nutrient 
concentration or oxygen levels are to be monitored, these sensors should be incorporated 
into the design. If a pump or motor is to be used, it must be small enough to fit into an 
incubator and also be usable at 37°C and in a humid environment. The forces needed for 
cellular stimulation are very small so it is important to ensure that the pump/motor has the 
capability to apply small forces accurately. In any design involving fluids, problems can 
arise with leaking fluid seals and, if possible, the need for seals should be reduced. 
However, in most cases, fluid seals are necessary and good design should decrease the 
problems with them. If a prototype bioreactor is being designed, it is worthwhile thinking 
about scale up opportunities for the bioreactor from the outset. This may mean designing a 
device that is relatively easy to enlarge without changing its characteristics or designing a 
www.intechopen.com
 Bioreactors in Tissue Engineering 325
 
1.2 Use of Bioreactors in Tissue Engineering  
A tissue engineering bioreactor can be defined as a device that uses mechanical means to 
influence biological processes (Darling & Athanasiou, 2003). Bioreactors can be used to aid 
in the in vitro development of new tissue by providing biochemical and physical regulatory 
signals to cells and encouraging them to undergo differentiation and/or to produce 
extracellular matrix prior to in vivo implantation. Bioreactors are devices in which biological 
or biochemical processes develop under a closely monitored and tightly controlled 
environment.  
Cells respond to mechanical stimulation and bioreactors can be used to apply mechanical 
stimulation to cells. This can encourage cells to produce extracellular matrix (ECM) in a 
shorter time period and in a more homogeneous manner than would be the case with static 
culture. For example, in comparisons between ECM protein levels of equine articluar 
chondrocytes cultured on polyglycolic acid scaffolds after 5 weeks in culture, constructs 
cultured under hydrostatic pressure showed significant improvements over constructs 
cultured in static medium (Carver & Heath, 1999). A benefit of ECM production is the 
increase in mechanical stiffness that it provides to the construct. A six-fold increase in 
equilibrium aggregate modulus (an intrinsic property of cartilage which is a measure of 
stiffness) was found after 28 days of culture in a compression bioreactor compared to free 
swelling controls (Mauck, et al., 2000). Another important application of bioreactors is in 
cellular differentiation. Mechanical stimulation can be used to encourage stem cells down a 
particular path and hence provide the cell phenotype required. Bioreactors can provide 
biochemical and physical regulatory signals that guide differentiation (Altman, et al., 2002). 
There is great potential for using mesenchymal stem cells and other multipotent cells to 
generate different cell types and bioreactors can play an important role in this process. 
As well as providing mechanical stimulation, bioreactors can also be used to improve 
cellular spatial distribution. A heterogeneous cell distribution is a major obstacle to 
developing any three-dimensional tissue or organ in vitro. Defects requiring tissue 
engineering solutions are typically many millimetres in size (Goldstein, et al., 2001). 
Scaffolds in such a size range are easily fabricated, however, problems arise when culturing 
cells on these scaffolds. As the size of the scaffold increases, diffusion of nutrients to the 
centre of the construct becomes more difficult. Static culture conditions result in scaffolds 
with few cells in the centre of the construct (Cartmell, et al., 2003). It is hypothesised that this 
is due to limited cell penetration during seeding, cell migration to the scaffold periphery 
during culture, or cell death in the centre of the scaffold (Glowacki, et al., 1998, Ishaug-Riley, 
et al., 1998, Goldstein, et al., 2001, Yu, et al., 2004, Gomes, et al., 2005). The only mechanism by 
which nutrients and waste can move when a scaffold is in static culture is by diffusion. It 
has been shown that despite homogeneous cell seeding, after long periods in culture, more 
cells are found on the periphery of constructs (Cartmell, et al., 2003) leading to peripheral 
encapsulation which hinders nutrient and waste exchange from the centre, resulting in core 
degradation of tissue engineered constructs. This is of major concern in the field of tissue 
engineering, and is a major obstacle in the formation of a viable tissue in vitro. For this 
reason, for a number of tissue types, the move towards clinical trials has been slow and 
progress to date in engineering significant quantities of functional tissue in vitro for 
implantation in humans in vivo has been somewhat disappointing.  
Thus, bioreactors can be used in tissue engineering applications to overcome problems 
associated with traditional static culture conditions, improve cellular distribution and 
 
accelerate construct maturation (Freed, et al., 2006) whilst applying biophysical signals to 
constructs to improve tissue formation in vitro prior to in vivo implantation. In general, 
bioreactors are designed to perform at least one of the following five functions, to (1) 
provide a spatially uniform cell distribution, (2) maintain the desired concentration of gases 
and nutrients in culture medium, (3) facilitate mass transport to the tissue, (4) expose the 
construct to physical stimuli and/or (5) provide information about the formation of 3D 
tissue (Vunjak-Novakovic, et al., 1998, Bancroft, et al., 2003)  
 
1.3 Bioreactor Design Requirements  
The design of the bioreactor should be as simple as possible e.g. avoiding the introduction of 
machined recesses which could become breeding grounds for micro-organisms. Simplicity 
in design should also mean that the bioreactor is quick to assemble and disassemble. Apart 
from being more efficient, this ensures that cell-seeded constructs inserted into the 
bioreactor are out of the incubator for the minimum amount of time possible. This 
minimises the risk to the cells and the experiment being undertaken. 
The detailed requirements for bioreactor design are tissue- and/or application- specific, 
however, there are a few general principles which have to be adhered to when developing a 
bioreactor. The material selection is very important as it is vital to ensure that the materials 
used to create the bioreactor do not elicit any adverse reaction from the cultured tissue. Any 
material which is in contact with media must be biocompatible or bioinert. This eliminates 
the use of most metals, although stainless steel can be used if it is treated so that chromium 
ions do not leach out into the medium. Numerous plastics comply with this constraint but 
there are further limitations on material selection that must also be kept in mind. Materials 
must be usable at 37°C in a humid atmosphere. They must be able to be sterilised if they are 
to be re-used. Bioreactor parts can be sterilised by autoclaving or disinfected by submersion 
in alcohol. If they are to be autoclaved, materials that can withstand numerous cycles of high 
temperature and pressure must be used in bioreactor manufacture. Alternatively, some non-
sterilisable disposable bioreactor parts may be used which can be replaced after each use of 
the bioreactor. Other material choices are between transparent or opaque and flexible or 
inflexible materials. Materials with different properties are needed for various components 
in the bioreactor. For example, transparent materials can be of benefit in allowing the 
construct to be monitored in the bioreactor during culture while flexible tubing can help 
with assembly of the bioreactor. 
The specific application of the bioreactor must be kept in mind during the design process to 
ensure that all the design constraints are met. If various parameters such as pH, nutrient 
concentration or oxygen levels are to be monitored, these sensors should be incorporated 
into the design. If a pump or motor is to be used, it must be small enough to fit into an 
incubator and also be usable at 37°C and in a humid environment. The forces needed for 
cellular stimulation are very small so it is important to ensure that the pump/motor has the 
capability to apply small forces accurately. In any design involving fluids, problems can 
arise with leaking fluid seals and, if possible, the need for seals should be reduced. 
However, in most cases, fluid seals are necessary and good design should decrease the 
problems with them. If a prototype bioreactor is being designed, it is worthwhile thinking 
about scale up opportunities for the bioreactor from the outset. This may mean designing a 
device that is relatively easy to enlarge without changing its characteristics or designing a 
www.intechopen.com
Tissue Engineering326
 
simple device of which many more can be made so that numerous scaffolds can be cultured 
at one time. 
 
2. Types of Bioreactors in Tissue Engineering 
Bioreactors are laboratory tissue culture devices that provide a controllable, mechanically 
active environment that can be used to study and potentially improve engineered tissue 
structure, properties and integration. Many tissue engineering studies employ conventional 
methods (static seeding) that result in constructs comprising a thin tissue like layer at the 
base of the scaffold due to gravitiational settling of the cells. In contrast convective mixing 
(spinner flasks) and convective flow (flow perfusion) can improve initial cell seeding and 
homogeneity, and thereby improve tissue architecture (Freed, et al., 2006). Numerous types 
of bioreactors including spinner flasks, rotating wall, compression, strain and flow perfusion 
bioreactors are used in various tissue engineering applications, which will all be discussed 
below. All of these bioreactors rely on forced media flow through and/or around the 
scaffold to provide nutrient and waste exchange within the scaffold.  
 
2.1 Spinner Flask Bioreactors 
One of the most basic bioreactors, a spinner flask induces mixing of oxygen and nutrients 
throughout the medium and reduces the concentration boundary layer at the construct 
surface. In a spinner flask, scaffolds are suspended at the end of needles in a flask of culture 
media. A magnetic stirrer mixes the media and the scaffolds are fixed in place with respect 
to the moving fluid (figure 2). Flow across the surface of the scaffolds results in eddies 
which are turbulent instabilities consisting of clumps of fluid particles that have a rotational 
structure superimposed on the mean linear motion of the fluid particles. They are associated 
with transitional and turbulent flow. It is via these eddies that fluid transport to the centre of 
the scaffold is thought to be enhanced (Goldstein, et al., 2001). Typically, spinner flasks are 
around 120 mL in volume (although much larger flasks of up to 8 litres have been used), are 
run at 50-80 rpm and 50% of the medium used in them is changed every two days 
(Freshney, 2000). Cartilage constructs have been grown in spinner flasks to thicknesses of 0.5 
mm (Freed & Vunjak-Novakovic, 2000). While this is an improvement on cartilage grown in 
static culture, it is still too thin for clinical use. Mass transfer in the flasks is not good enough 
to deliver homogeneous cell distribution throughout scaffolds and cells predominantly 
reside on the construct periphery.  
 
 Fig. 2. A spinner flask bioreactor. Scaffolds are suspended in medium and the medium is 
stirred using a magnetic stirrer to improve nutrient delivery to the scaffold  
 
2.2 Rotating Wall Bioreactors 
The rotating wall bioreactor was developed by NASA (Schwarz, et al., 1992). It was 
originally designed with a view to protecting cell culture experiments from high forces 
during space shuttle take off and landing. However, the device has proved useful in tissue 
engineering here on Earth. In a rotating wall bioreactor, scaffolds are free to move in media 
in a vessel. A rotating wall vessel bioreactor consists of a cylindrical chamber in which the 
outer wall, inner wall, or both are capable of rotating at a constant angular speed (figure 3). 
The vessel wall is then rotated at a speed such that a balance is reached between the 
downward gravitational force and the upward hydrodynamic drag force acting on each 
scaffold. The wall of the vessel rotates, providing an upward hydrodynamic drag force that 
balances with the downward gravitational force, resulting in the scaffold remaining 
suspended in the media. Dynamic laminar flow generated by a rotating fluid environment is 
an alternative and efficient way to reduce diffusional limitations of nutrients and wastes 
while producing low levels of shear. Media can be exchanged by stopping the rotation 
temporarily or by adding a fluid pump whereby media is constantly pumped through the 
vessel. Fluid transport is enhanced in a similar fashion to the mechanism in spinner flasks 
and the devices also provide a more homogeneous cell distribution than static culture. Gas 
exchange occurs through a gas exchange membrane and the bioreactor is rotated at speeds 
of 15-30 rpm. Cartilage tissue of 5 mm thickness has been grown in this type of bioreactor 
after seven months of culture (Freed, et al., 1997). As tissue grows in the bioreactor, the 
rotational speed must be increased in order to balance the gravitational force and ensure the 
scaffold remains in suspension.  
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 Fig. 3. A rotating wall vessel bioreactor. Scaffolds are suspended in medium due to 
opposing gravitational and drag forces 
 
2.3 Compression Bioreactors 
Another widely used type of bioreactor is the compression bioreactor. This class of 
bioreactor is generally used in cartilage engineering and can be designed so that both static 
and dynamic loading can be applied. This is because static loading has been found to have a 
negative effect on cartilage formation in comparison to dynamic loading, which is more 
representative of physiological loading (Darling & Athanasiou, 2003). In general, 
compression bioreactors consist of a motor, a system providing linear motion and a 
controlling mechanism used to provide displacements of different magnitudes and 
frequencies. A signal generator can be used to control the system including load cells while 
transformers can be used to measure the load response and imposed displacement (Huang, 
et al., 2004). The load can be transferred to the cell-seeded constructs via flat platens which 
distribute the load evenly (Thorpe, et al., 2008), however in a device for stimulating multiple 
scaffolds simultaneously, care must be taken that the constructs are of similar height or the 
compressive strain applied will vary as the scaffold height does. Mass transfer is improved 
in dynamic compression bioreactors over static culture (as compression causes fluid flow in 
the scaffold) which results in the improvement of the aggregate modulus of the resulting 
cartilage tissue to levels approaching those of native articular cartilage (Mauck, et al., 2000).  
 
2.4 Strain Bioreactors 
Tensile strain bioreactors have been used in an attempt to engineer a number of different 
types of tissue including tendon, ligament, bone, cartilage and cardiovascular tissue. Some 
designs are very similar to compression bioreactors, only differing in the way the force is 
transferred to the construct. Instead of flat platens as in a compression bioreactor, a way of 
clamping the scaffold into the device is needed so that a tensile force can be applied. Tensile 
strain has been used to differentiate mesechymal stem cells along the chondrogenic lineage. 
A multistation bioreactor was used in which cell-seeded collagen-glycosaminoglycan 
scaffolds were clamped and loaded in uniaxial tension (McMahon, et al., 2008). 
Alternatively, tensile strain can also be applied to a construct by attaching the construct to 
anchors on a rubber membrane and then deforming the membrane. This system has been 
used in the culture of bioartificial tendons with a resulting increase in Young’s modulus 
over non-loaded controls (Garvin, et al., 2003).  
 
 
2.5 Hydrostatic Pressure Bioreactors 
In cartilage tissue engineering, hydrostatic pressure bioreactors can be used to apply 
mechanical stimulus to cell-seeded constructs. Scaffolds are usually cultured statically and 
then moved to a hydrostatic chamber for a specified time for loading. Hydrostatic pressure 
bioreactors consist of a chamber which can withstand the pressures applied and a means of 
applying that pressure. For example, a media-filled pressure chamber can be pressurised 
using a piston controlled by an actuator (Darling & Athanasiou, 2003). For sterility, the 
piston can apply pressure via an impermeable membrane so that the piston itself does not 
come into contact with the culture media. Variations on this design include a water-filled 
pressure chamber which pressurises a media-filled chamber via an impermeable film and is 
controlled using a variable backpressure valve and an actuator (Watanabe, et al., 2005).  
 
2.6 Flow Perfusion Bioreactors 
Culture using flow perfusion bioreactors has been shown to provide more homogeneous 
cell distribution throughout scaffolds. Collagen sponges have been seeded with bone 
marrow stromal cells and perfused with flow. This has resulted in greater cellularity 
throughout the scaffold in comparison to static controls, implying that better nutrient 
exchange occurs due to flow (Glowacki, et al., 1998). Using a calcium phosphate scaffold, 
abundant extracellular matrix (ECM) with nodules of calcium phosphate was noted after 19 
days in steady flow culture (Janssen, et al., 2006). In comparisons between flow perfusion, 
spinner flask and rotating wall bioreactors, flow perfusion bioreactors have proved to be the 
best for fluid transport. Using the same flow rate and the same scaffold type, while cell 
densities remained the same using all three bioreactors, the distribution of the cells changed 
dramatically depending on which bioreactor was used. Histological analysis showed that 
spinner flask and static culture resulted in the majority of viable cells being on the periphery 
of the scaffold. In contrast, the rotating wall vessel and flow perfusion bioreactor culture 
resulted in uniform cell distribution throughout the scaffolds (Goldstein, et al., 2001, Yu, et 
al., 2004).  
Flow perfusion bioreactors generally consist of a pump and a scaffold chamber joined 
together by tubing. A fluid pump is used to force media flow through the cell-seeded 
scaffold. The scaffold is placed in a chamber that is designed to direct flow through the 
interior of the scaffold. The scaffold is kept in position across the flow path of the device and 
media is perfused through the scaffold, thus enhancing fluid transport. Media can easily be 
replaced in the media reservoir (figure 4). However, the effects of direct perfusion can be 
highly dependent on the medium flow rate. Therefore optimising a perfusion bioreactor for 
the engineering of a 3D tissue must address the careful balance between the mass transfer of 
nutrients and waste products to and from cells, the retention of newly synthesised ECM 
components within the construct and the fluid induced shear stresses within the scaffold 
pores. 
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 Fig. 4. A flow perfusion bioreactor, media is forced through the scaffold in the scaffold 
chamber by the syringe pump (Jaasma, et al., 2008) 
 
3. Tissue Formation in Bioreactor Systems 
3.1 Flow Perfusion Bioreactors for Bone Tissue Engineering 
Bone grafts are required to aid bone defect and non-union healing, and restore function to 
the damaged area as quickly and completely as possible (Perry, 1999). They are required in a 
number of procedures e.g. replacing diseased bone, filling bone voids, reconstructive 
surgery and in spinal fusion operations. The use of bone grafts substitutes (autografts, 
allografts and xenografts) are associated with donor site morbidity, small volume of donor 
tissue harvested, disease transmission, infection and chronic pain (Perry, 1999, Langer, 
2000). Therefore, attention has turned to bone tissue engineering.  
It has been shown that fluid flow can stimulate bone cells to increase levels of bone 
formation markers (Reich & Frangos, 1991, Klein-Nulend, et al., 1997, You, et al., 2001, 
Cartmell, et al., 2003, Li, et al., 2004, Batra, et al., 2005, Kreke, et al., 2005, Jaasma & O'Brien, 
2008) and its use could improve mineralisation of the scaffold on which cells are seeded. 
Flow perfusion bioreactors increased alkaline phosphatase (ALP) expression after 7 and 14 
days of culture compared to constructs cultured in spinner flasks or rotating wall vessels 
(Goldstein, et al., 2001), and are more commonly used than any other bioreactor for use in 3-
D stimulation studies. In one study, pre-osteoblastic MC3T3-E1 cells were seeded on 
decalcified human trabecular bone, the flow rate of perfusion altered and the mRNA 
expression of Runx2, Osteocalcin (OC) and ALP measured (Cartmell, et al., 2003). It was 
found that using a steady flow rate of 1 mL/min killed a majority of the cells on the scaffold 
after 7 days in culture. However, a flow rate of 0.01 mL/min led to a high proportion of 
viable cells both on the surface and inside the scaffold. This compared favourably to static 
culture, where cells were predominantly on the periphery (Cartmell, et al., 2003).  
During locomotion, bone cells are primarily subjected to oscillatory and pulsatile flow in 
vivo (Jacobs, et al., 1998). Results from 2D cultures show that osteoblasts are more responsive 
to pulsatile than steady and oscillatory flow (Jacobs, et al., 1998). In our laboratory, a flow 
perfusion bioreactor has been developed to examine the effects of different flow profiles on 
 
cell-seeded collagen-glycosaminoglycan scaffolds (Jaasma, et al., 2008). The scaffold chamber 
was specifically designed to ensure that the compliant scaffold was under perfusive flow. 
This involved using a scaffold of larger diameter than the flow path and using spacers to 
ensure the scaffold was under 10% compression during culture. A programmable syringe 
pump was used in order to stimulate the cell-seeded constructs using different flow profiles. 
This device demonstrated that intermittent flow perfusion is advantageous for mechanically 
stimulating osteoblasts while maintaining cell viability. It was found that intermittent 
dynamic flow caused greater stimulation than a continuous low flow rate (Jaasma & 
O'Brien, 2008). Cyclyoxygenase-2 (COX-2) and osteopontin (OPN) expression increased due 
to culture in the bioreactor, as did prostaglandin E2 (PGE2) production. Whilst, in a more 
recent study in our lab, it was found that the insertion of short term rest periods (5, 10 and 
15 seconds) combined with long term rests (7 hours) provided an enhanced osteogenic 
response compared to constructs cultured in static culture, whilst simultaneously improving 
cellular spatial distribution. The use of short term rests upregulated COX-2, PGE2 and OPN 
(Partap, et al., 2009, Plunkett, et al., 2009). PGE2 levels were also found to increase over static 
controls when a calcium phosphate scaffold was cultured in a flow perfusion bioreactor 
with a flow rate of 0.025 mL/min. A stimulus of 30 minutes of oscillatory flow at 1 Hz with 
a 40 mL/min peak superimposed on steady flow increased levels of PGE2. The number of 
cells left residing on the scaffolds decreased due to this large dynamic stimulus but this 
decrease was not found to be statistically significant to static culture (Vance, et al., 2005).  
Results suggest that the increased cell proliferation and matrix mineralisation in the centre 
of the scaffold resulting from culture in a flow perfusion bioreactor are primarily due to 
better nutrient and waste exchange. However, the increased mineral deposition with an 
increase in flow rate and numerous 2D experiments indicate that cells are also stimulated by 
the flow-induced shear stress. Sikavitsas et al. (2003) added various amounts of dextran to 
the media to increase its viscosity. This allowed for the shear stress magnitude experienced 
by the cells on the scaffold to be varied independently while keeping the flow rate constant. 
Mineral deposition on the scaffold was found to be proportional to the magnitude of the 
shear stress imposed on the cells. Thus, while flow perfusion does appear to increase the 
ability of cells to remain viable at the centre of the scaffold, it also serves as a means of 
increasing matrix production and mineralisation on the scaffold (Sikavitsas, et al., 2003).  
 
3.2 Compression Bioreactor for Cartilage Tissue Engineering 
Cartilage is a supporting tissue containing chondroitin sulphates, collagen and elastic fibres 
and cells. The cells present in cartilage are known as chondrocytes and they are situated in 
lacunae in the cartilage matrix. Nutrient and waste product exchange occurs purely by 
diffusion through the cartilage matrix. It is an avascular, aneural and alymphatic tissue. The 
healing response of damaged cartilage is dependent upon the depth of the lesion. When 
minor damage occurs to cartilage, it can be repaired by appositional growth, but when 
severe damage occurs, it is repaired without complete restoration. This is thought to be due 
to the low metabolic activity of chondrocytes and its avascular nature (Martini, 2002). 
Currently, autologous chonrdocyte implantation (ACI), osteochondral grafting and bone 
marrow stimulation techniques are used to stimulate the regeneration of native cartilage. 
However, these techniques generally result in the formation of fibrocartilage which has poor 
mechanical properties and does not perform as well as native cartilage. Cartilage tissue 
engineering may offer a solution to this problem. There are three types of cartilage: hyaline, 
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elastic and fibrocartilage. Joints can contain both hyaline cartilage and fibrocartilage, with 
the more flexible hyaline cartilage covering the bone and the more durable fibrocartilage 
acting as a shock-absorber between bones. As a joint moves, there is motion between two 
articulating layers of cartilage. This deforms the cartilage, causes fluid flow within it and 
induces a hydrostatic pressure load on it. These mechanical forces affect the chondrocytes in 
the cartilage. The force applied, along with the length of time it is applied for and the 
frequency of application modifies the response of chondrocytes (Mauck, et al., 2007). This is 
useful in bioreactor design and for use in cartilage tissue engineering; if the correct 
stimulation pattern is used, chondrocytes can be induced to produce more extracellular 
matrix and this can result in more cartilage-like tissue being formed.    
After twenty weeks in static culture, the aggregate modulus of tissue-engineered cartilage 
was 179±9 kPa. This is 40% of the value reported for native cartilage (Ma & Langer, 1999). At 
twenty five weeks, the modulus had not increased further so this may be the closest 
approximation to cartilage that can be cultured without the aid of a bioreactor. The most 
commonly used bioreactors in cartilage tissue engineering are compression bioreactors. 
When free swelling controls were compared to dynamically loaded agarose gels, after 28 
days in culture, there was a six-fold increase in the equilibrium aggregate modulus for the 
loaded gels (Mauck, et al., 2000). A sinusoidal strain of 10% at 1 Hz was applied to the gels 
for five days per week for a total of three hours per day with a rest period of one hour 
between each hour of loading. This complex loading pattern was deemed to be 
physiological and it resulted in increased glycosaminoglycan content over free swelling 
controls after 21 days in culture. The combination of increased modulus and increased 
glycosaminoglycan formation over free swelling controls after only four weeks in culture 
demonstrates the benefits of bioreactor culture in cartilage tissue engineering. Compression 
bioreactors have also been used to examine the effect of loading on the differentiation of 
bone marrow mesenchymal stem cells down the chondrocytic lineage. Growth factors such 
as transforming growth factor (TGF-) can also be used to encourage differentiation. In a 
study comparing the use of compressive loading, the use of TGF- and the use of a 
combination of loading and TGF-, it was found that compressive loading alone was just as 
effective at inducing chondrogenic differentiation as TGF- or TGF- plus loading (Huang, 
et al., 2004).  
 
4. Bioreactors: State of the Art and Future Directions 
The use of bioreactors has brought us a step closer to engineering numerous tissue types. 
Recently, a bioreactor was used to culture a tissue engineered trachea that was successfully 
implanted into a patient. A donor trachea was decellularized and subsequently seeded with 
the patients own cells. The bioreactor was specifically designed to seed and culture different 
cell types on either side of the donor tissue to allow for nutrient supply and waste removal, 
to provide biomechanical cues in the form of a hydrodynamic shear stress, as well as being 
designed to be autoclaved and handled in a sterile manner. The bioreactor rotated the 
trachea around its longitudinal axis so that a shear stress was applied to the cells to 
stimulate them and to ensure the even distribution of nutrients and waste. In addition to the 
rotation of the graft, the culture medium was continuously mixed to increase oxygenation 
and the exchange of waste and nutrients in the bioreactor chamber (Macchiarini, et al., 2008). 
 
 
However, most bioreactors at present are specialised devices with a low volume output. 
Their assembly is often time consuming and labour intensive. Many also exhibit operator 
dependent variability. Ways of minimizing the time and effort needed to form tissue must 
be sought if costs are to be reduced so that engineered tissues can be routinely used in 
clinical environments. In the future, scaled up versions of some devices (which may be 
automated) could potentially supply larger amounts of tissue. The ideal bioreactor would 
generate the required amount of tissue after a defined culture period. In addition, 
development of tissue could be monitored throughout the culture period through the 
incorporation of for example video microscopy and microcomputed tomography (CT) for 
observing the structural properties of the growing tissue. A better understanding of the 
different effects of mechanical stimulation on cell signalling and mechanotransduction is 
also needed. This can be achieved through the use of existing simple bioreactors in 
conjunction with numerical simulation of culture conditions to minimise the number of 
experiments needed. This may be the future for bioreactors in tissue engineering. 
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